HM Payson & Co’s Guardant Health GH Stock Holding History
Bought
Maintained
Sold
Other funds holding GH
DTC
HM Payson & Co's GH Position: Q2 2026 in Review
HM Payson & Co held its Guardant Health (GH) position steady in Q2 2026 at 1,000 shares worth $150K. The position accounts for ﹤0.01% of the portfolio, ranked #501.
HM Payson & Co first reported a position in GH in Q2 2019 and has held it in 29 quarters since. 597 funds tracked by Wall St. Rank hold GH as of Q2 2026.
- HM Payson & Co held 1,000 shares of Guardant Health worth $150K as of Q2 2026.
- HM Payson & Co left its Guardant Health share count unchanged in Q2 2026.
- Guardant Health made up ﹤0.01% of HM Payson & Co's portfolio in Q2 2026, its #501 holding.
- HM Payson & Co first reported a position in Guardant Health in Q2 2019 and has held it in 29 quarters since.
- 597 funds tracked by Wall St. Rank held Guardant Health as of Q2 2026.
Based on HM Payson & Co's 13F filing for Q2 2026, filed 17 Jul 2026.